Skip to main content
Talal Hilal, MD, Hematology, Phoenix, AZ

TalalHilalMD

Hematology • Phoenix, AZ

Hematologic Oncology

Assistant Professor of Medicine

Join to view full profile

Dr. Hilal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Hilal's full profile

Already have an account?

Summary

  • The Changing Standards for FDA Oncology Approvals: Talal Hilal, MD

    The FDA approval process is in place to ensure that drugs are safe and effective before they are made available to the public. But do the clinical trials that l

    Substandard control arms question some new cancer drugs' utility - STAT

    The rapid pace of new cancer drugs approved by the FDA, 16 in 2018 alone, is - on the surface - good news for people with cancer.

Education & Training

  • Mayo Clinic College of Medicine and Science (Phoenix)
    Mayo Clinic College of Medicine and Science (Phoenix)Fellowship, Hematology and Medical Oncology, 2016 - 2019
  • University of Kentucky College of Medicine
    University of Kentucky College of MedicineResidency, Internal Medicine, 2013 - 2016
  • Royal College of Surgeons in Ireland - Medical University of Bahrain
    Royal College of Surgeons in Ireland - Medical University of BahrainClass of 2012

Certifications & Licensure

  • AZ State Medical License
    AZ State Medical License 2016 - 2026
  • MS State Medical License
    MS State Medical License 2019 - 2023
  • OR State Medical License
    OR State Medical License 2018 - 2018
  • KY State Medical License
    KY State Medical License 2014 - 2016
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Authored Content

  • Practices in Haematology Contributing to Unnecessary ToxicityApril 2020
  • The Step 1 Score Reporting Change – A Step in the Right Direction for IMGs?February 2020
  • A Millennial Doctor’s Experience with Industrial MedicineMay 2019

Press Mentions

  • Promising Developments in Chronic Lymphocytic Leukemia Treatment
    Promising Developments in Chronic Lymphocytic Leukemia TreatmentAugust 20th, 2024
  • Understanding Follicular Lymphoma
    Understanding Follicular LymphomaApril 28th, 2024
  • Control Arm Quality in Randomized Oncology Trials Leading to FDA Approval
    Control Arm Quality in Randomized Oncology Trials Leading to FDA ApprovalMay 17th, 2019
  • Join now to see all

Professional Memberships

Other Languages

  • Arabic

Dr. Talal Hilal, Dr. Talal Hilal, MD, Dr. T Hilal